STRAT7 helps businesses turn change into commercial advantage by harnessing the power of data and real-time insights.
Strategic insight & analytics
STRAT7 helps businesses turn change into commercial advantage by harnessing the power of data and real-time insights.
Strategic insight & analytics
Healthcare is being reshaped by scientific breakthroughs, technological disruption, and the rise of patients as empowered consumers. STRAT7 Health helps you see what’s coming and act before markets shift. We bring foresight, strategic clarity, and bold thinking that turn complexity into competitive advantage.
Whether it’s shaping investment decisions for early-stage assets, building portfolio strategies that anticipate regulatory and competitive shifts, crafting launch plans with positioning that resonates with clinicians and patients for years not months, or driving therapeutic franchise growth before opportunities become competitive battlegrounds – we help you move forward with conviction.
“They are true partners… they truly come up with tools, outputs and ideas that can be taken forward in a pragmatic way. If they had a Google review page – it would have over 1,000 five star reviews. If they were a restaurant, they’d have a double Michelin star. That is genuinely how it feels to work with them.”
Hazim El-Rais
Head of Commercial Operations, Leading biotechnology company
Our integrated ecosystem brings together senior experts in consulting, insight, and foresight — complemented by perspectives from other sectors. This blend gives you a richer, more rounded understanding of your challenges and ensures your strategy is shaped by both deep industry knowledge and broader commercial thinking.
Our teams are led by trusted advisors with over 20 years of healthcare experience and deep industry knowledge who understand you and your business. We build relationships where your teams feel challenged, supported, and inspired to embrace the outcomes and make them happen.
We utilise both proven methodologies and sophisticated new approaches – from hybrid segmentation that drives deployment to AI tools that stimulate creativity and bring your customer into the decision making. The right methodology for the right challenge, delivered by specialists who can execute brilliantly.












With 20 years of deep sector knowledge, we understand the distinct challenges and opportunities each sector faces – whether you’re an established pharmaceutical company, a fast-moving biotech, or a medtech innovator. Our experience spans the full spectrum of healthcare businesses.
From early-stage opportunity assessment and launch strategy to franchise optimisation and lifecycle management, we help established pharmaceutical companies make the strategic decisions that drive commercial performance in competitive markets.
“STRAT7 truly partnered with us to make sure we ended the study with the answers we needed to make decisions for our asset’s development. They are creative problem solvers and insightful, sophisticated researchers”.
Director, Global New Asset Strategy, Global Pharma
For fast-moving biotech firms, we bring structure to ambiguity. We help define the market, shape value propositions and prepare for critical milestones like funding, partnerships and launch.
“The research has been transformational in helping us understand the critical touch points in the patient pathway – finding barriers to identifying eligible patients that could otherwise be missed. This project has been the cornerstone of some pivotal decisions in our planning and actions for the year”.
Associate Director, Product Management, Gilead Sciences Ltd
We help medical devices, equipment and digital health businesses understand evolving customer expectations, navigate regulatory and reimbursement challenges, and overcome adoption barriers – turning technical innovation into commercial success.
“Working with STRAT7 was an exceptional experience. They were highly collaborative and consistently went above and beyond, leading workshops that ensured our team not only understood the research results but could activate on them effectively. Their approach was thorough, accommodating, and responsive to every request, making them a trusted partner throughout the process”.
Senior Managers from Insights and R&D, Medical Devices Company
For CDMOs and healthcare service providers, we provide the market intelligence and customer insights that inform strategic positioning, capability investment, and commercial strategy in a rapidly evolving B2B market.
We combine proven methodologies with innovative approaches to deliver the perspectives that shape winning strategies, from segmentation that drives decisions to cultural insights that spot shifts before competitors.
With over 2,000 segmentations delivered across industries, we understand how to make segmentation drive real business impact – not just describe your market, but shape strategic decisions. We set clear ambitions, choose the right segmentation approach for your needs, and build deployment plans that ensure insights translate into action. From hybrid segmentation that integrates with CRM systems to strategic frameworks that guide portfolio decisions, we make segmentation work in practice.
Healthcare customers have the same expectations as they do in banking, retail, or consumer goods – yet pharma has historically been product-first, not customer-first. We help you spot cultural shifts before competitors do and adapt your strategy to stay relevant. From ethnographic research that captures authentic patient realities to semiotic analysis that forecasts future scenarios, we give you a culturally-charged advantage that shapes positioning, messaging, and innovation.
Insight communities give you direct access to clinicians and patients for agile, real-time decision-making – ensuring their voices shape your strategy, not just validate it. Whether you need a long-term resource across multiple projects or a focused community for a single purpose like pre-launch strategy, communities offer a cost-effective way to stay connected to the stakeholders who matter most.
Our AI platform, Nucleus, is purpose-built for insight professionals – not generic AI adapted for research. With over 20 years of automated insight solutions, we understand how to use AI to accelerate insights without compromising quality or security. Nucleus powers all our healthcare capabilities: rapid synthesis of complex datasets through STRAT7 GPT, qualitative research with WhyCatcher, segment chatbots that bring customer voices into decision-making, and digital twins for strategic planning. We match the right tools to the right challenge, with human expertise at every critical decision point and enterprise-grade data security as standard.
Whether you’re shaping launch strategy, optimising franchise performance, or positioning pipeline assets, we’re here to help you move forward with confidence.
London
|
New York
|
Amsterdam
|
Stockholm
|
Sydney